Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 1/2 3Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 90Gastrointestinal 78Thoracic 68Sarcoma 47Head & Neck 41Genitourinary 23Breast 19Lymphoid 18Gynecologic 18Other hematologic neoplasm 16Dermatologic 16Tumor-Agnostic 9Plasma cell 8Other solid neoplasm 8Myeloid 7Endocrine 2Other neoplasm 1Other 1NET 1Classical hematology 1

Conditions

Neoplasms, Plasma Cell 1Mucositis 1Lymphoma 1Leukemia 1

Interventions

Metformin 2rosiglitazone-metformin combination 1mirabegron 1lorcaserin 1exemestane 1atezolizumab 1angiotensin I (1-7) 1Traumeel S 1Tirzepatide 1TIC10 compound 1Sodium Chloride 1Rosiglitazone 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Melphalan 1Leflunomide 1Hydroquinones 1Fish Oils 1Fibroblast Growth Factor 7 1Drug Therapy 1Docosahexaenoic Acids 1Cisplatin 1Cholestyramine Resin 1CBLB502 1Ascorbic Acid 1Acupuncture Therapy 1ART123 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Radiotherapy × Other × Clear all
NCT00070616 2014-10-24

Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support

Swedish Orphan Biovitrum

Phase 1 Completed
25 enrolled
LymphoidOtherOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Mucositis, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡